igf 1 lr3 vs igf2 lr3 IGF-1 LR3: Nasal Spray vs. Subcutaneous Injection Comparison IGF-1 LR3 – Supra Chems
Description
Targeting mitochondria as a therapeutic approach for parkinsons disease

PMID: 42197099 Durmaz A, Kanmaz H, Yilmaz B, et al

doi: 10.1016/S0076-6879(02)47028-0

Mueller et al
